Performance of PROMIS Measures to Assess Fatigue and Sleep Symptom Severity Among African American Patients Newly Diagnosed With Obstructive Sleep Apnea.

The study was a pilot with 26 participants, all African American adults with prediabetes and newly diagnosed OSA who had not started treatment, so the findings may not apply to other racial groups, people with diabetes, or people already receiving OSA treatment. The sample was recruited before treatment partly because of a national sleep equipment recall and supply chain shortages, so results may not reflect symptom severity after treatment begins. The study compared scores at one time point and did not test whether these measures change care or patient outcomes. PROMIS Sleep Disturbance did not correlate with the longer fatigue measure, so it should not be interpreted as a fatigue measure in this sample.

This work was supported by a National Institutes of Health funded center pilot grant, and the authors reported no conflicts of interest.

Do not conclude that the PROMIS Sleep Disturbance measure assesses fatigue or that these brief measures improve care. In this study, PROMIS Sleep Disturbance scores were not associated with the longer fatigue questionnaire, and the study did not test patient outcomes.